Prédispositions génétiques aux cancers : Actualités et perspectives en 2005

Dominique Stoppa-Lyonnet; Gilbert Lenoir

doi:doi:10.1051/medsci/20052111962

Accès gratuit

Numéro		Med Sci (Paris) Volume 21, Numéro 11, Novembre 2005


Page(s)		962 - 968
Section		M/S revues
DOI		http://dx.doi.org/10.1051/medsci/20052111962
Publié en ligne		15 November 2005

Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10 : 789–99.
Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004; 4 : 177–83.
Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250 : 1684–9.
Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer : results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 1993; 52 : 678–701.
Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266 : 66–71.
De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4 : 769–80.
Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3 : 903–11.
Waite KA, Eng C. From developmental disorder to heritable cancer: it’s all in the BMP/TGF-beta family. Nat Rev Genet 2003; 4 : 763–73.
Eng C, Kiuru M, Fernandez MJ, et al. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003; 3 : 193–202.
Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297 : 606–9.
Bougeard G, Charbonnier F, Moerman A, et al. Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet 2003; 72 : 213–6.
Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1 : 55–67.
Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23 : 276–92.
Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86 : 76–83.
Eisinger F, Bressac B, Castaigne D, et al. Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l’ovaire (mise à jour 2004). Bull Cancer 2004; 91 : 219–37.
Olschwang S, Bonaiti C, Feingold J, et al. Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer), et des prédispositions héréditaires aux cancers du côlon et de l’endomètre. Bull Cancer 2004; 91 : 303–15.
Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004; 23 : 6471–6.
Pharoah PD, Dunning AM, Ponder BA, et al. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004; 4 : 850–60.
Andrieu N, Goldstein AM. The case-combined-control design was efficient in detecting gene-environment interactions. J Clin Epidemiol 2004; 57 : 662–71.

[1] Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10 : 789–99.

[2] Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004; 4 : 177–83.

[3] Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250 : 1684–9.

[4] Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer : results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 1993; 52 : 678–701.

[5] Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266 : 66–71.

[6] De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4 : 769–80.

[7] Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3 : 903–11.

[8] Waite KA, Eng C. From developmental disorder to heritable cancer: it’s all in the BMP/TGF-beta family. Nat Rev Genet 2003; 4 : 763–73.

[9] Eng C, Kiuru M, Fernandez MJ, et al. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003; 3 : 193–202.

[10] Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297 : 606–9.

[11] Bougeard G, Charbonnier F, Moerman A, et al. Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet 2003; 72 : 213–6.

[12] Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1 : 55–67.

[13] Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23 : 276–92.

[14] Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86 : 76–83.

[15] Eisinger F, Bressac B, Castaigne D, et al. Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l’ovaire (mise à jour 2004). Bull Cancer 2004; 91 : 219–37.

[16] Olschwang S, Bonaiti C, Feingold J, et al. Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer), et des prédispositions héréditaires aux cancers du côlon et de l’endomètre. Bull Cancer 2004; 91 : 303–15.

[17] Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004; 23 : 6471–6.

[18] Pharoah PD, Dunning AM, Ponder BA, et al. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004; 4 : 850–60.

[19] Andrieu N, Goldstein AM. The case-combined-control design was efficient in detecting gene-environment interactions. J Clin Epidemiol 2004; 57 : 662–71.

Prix Nobel 2012